Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial - van der Heijde, D; Song, I; Pangan, AL (Lancet, 2019)
et al.